Biotricity (OTCMKTS:BTCY) Stock Price Up 4.1%

Shares of Biotricity, Inc. (OTCMKTS:BTCYGet Rating) traded up 4.1% during mid-day trading on Friday . The stock traded as high as $0.81 and last traded at $0.77. 80,268 shares changed hands during mid-day trading, a decline of 19% from the average session volume of 99,622 shares. The stock had previously closed at $0.74.

Biotricity Stock Performance

The firm has a market cap of $39.75 million, a P/E ratio of -1.66 and a beta of 2.04. The business’s 50-day simple moving average is $0.79 and its 200 day simple moving average is $0.99.

Biotricity (OTCMKTS:BTCYGet Rating) last issued its quarterly earnings data on Monday, November 14th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.08) by ($0.01). Biotricity had a negative return on equity of 6,795.29% and a negative net margin of 265.11%. The firm had revenue of $2.38 million during the quarter, compared to the consensus estimate of $2.50 million. As a group, equities research analysts expect that Biotricity, Inc. will post -0.36 EPS for the current year.

Institutional Trading of Biotricity

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. State Street Corp grew its position in shares of Biotricity by 586.8% during the 1st quarter. State Street Corp now owns 135,295 shares of the company’s stock valued at $307,000 after acquiring an additional 115,595 shares during the period. Beacon Pointe Advisors LLC purchased a new position in Biotricity during the first quarter valued at $77,000. Bouchey Financial Group Ltd bought a new stake in Biotricity during the second quarter valued at about $47,000. Virtu Financial LLC purchased a new stake in Biotricity in the first quarter worth about $50,000. Finally, Jane Street Group LLC bought a new position in shares of Biotricity in the first quarter worth about $27,000. 4.83% of the stock is owned by hedge funds and other institutional investors.

About Biotricity

(Get Rating)

Biotricity, Inc is a medical technology company, which is focused on biometric data monitoring solutions. It is also involved in delivering remote monitoring solutions to the medical, healthcare, and consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.

Recommended Stories

Receive News & Ratings for Biotricity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotricity and related companies with MarketBeat.com's FREE daily email newsletter.